The Bayesian Model on Human Papillomavirus Vaccination in Italy Lacks Transparency

The Bayesian Model on Human Papillomavirus Vaccination in Italy Lacks Transparency

To the Editor: We refer to a recently published article that shows a new Bayesian method, applied to assess a vaccination strategy preventing human papillomavirus (HPV)-related diseases. The article basically describes a model for the economic evaluation of the quadrivalent HPV vaccine in Italy, concluding that it is a costeffective strategy. Although any model, Bayesian or Frequentist, should ...

Exploring reasons for non-vaccination against human papillomavirus in Italy

BACKGROUND In Italy, free-of-charge HPV vaccination is offered to 11-year-old girls since 2007. The National Immunization Plan established the target coverage at a minimum of 70%; it should increase to 95% within 3-year time frame. In 2012, four year after the introduction of HPV vaccination, coverage was stable at 69%. We conducted a national cross-sectional study to explore barriers to vaccin...

Model for Assessing Human Papillomavirus Vaccination Strategies

We present a transmission dynamic model that can assess the epidemiologic consequences and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent (types 6/11/16/18) human papillomavirus (HPV) vaccine in a setting of organized cervical cancer screening in the United States. Compared with current practice, vaccinating girls before the age of 12 years would reduc...

Vaccination against human papillomavirus

Human papillomavirus infection is common and causes different manifestations. This infection is a public health concern because it has been associated with genital tract malignant diseases among men and women. Currently two vaccines are available to prevent the human papillomavirus infection and its associated diseases.

Human papillomavirus vaccination.